21-year-old Long Island man is the first person in New York history to be cured of sickle cell anemia

21-year-old Long Island man is the first person in New York history to be cured of sickle cell anemia

A 21-year-old Long Island patient has been cured of sickle cell anemia thanks to a gene therapy treatment.

Sickle Cell Disease Treatment Market: New Therapies and Breakthroughs - PRwire Center

The Sickle Cell Disease Treatment Market is expected to grow at 20.1% CAGR by 2030. The sickle cell disease treatment market has seen substantial growth in recent years, driven by advancements in healthcare technology, increasing patient demand, and evolving regulatory landscapes. This report provides a detailed analysis of market size, share, and trends, offering valuable insights into the current and future outlook of the industry. Sickle Cell…

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

PENNINGTON, N.J., March 12, 2025 /PRNewswire/ — Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral therapies for sickle cell disease (SCD). This investment underscores Zynext Ventures’ commitment to supporting disruptive healthcare innovations that address signif…